IL-6-6331 (T/C, rs10499563) is associated with decreased risk of gastric cancer in Northern Chinese

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 12, 2013, Pages 7467-7472

  Yang, Li ^a,b   Sun, Ming Jun ^a   Liu, Jing Wei ^a   Xu, Qian ^a   Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b People's Hospital of Liaoning Province   (China)

Author keywords

Atrophic gastritis; Gastric cancer; H. pylori; IL 6; Polymorphism

Indexed keywords

INTERLEUKIN 6; VIRUS DNA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ASIAN; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH TUMOR; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84893377111     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.12.7467     Document Type: Article

References (21)

1. Ashizawa T, Okada R, Suzuki Y, et al (2005). Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor. Gastric Cancer, 8, 124-31.
2. Atherton JC (2006). The pathogenesis of Helicobacter pyloriinduced gastro-duodenal diseases. Ann Rev Pathol, 1, 63-96.
3. Bauer J, Ganter U, Geiger T, et al (1988). Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood, 72, 1134-40.
4. Chen HF, Mai JR, Wan JX, et al (2013). Role of a novel functional variant in the PPP2R1A promoter on the regulation of PP2A-Aalpha and the risk of hepatocellular carcinoma. PLoS One, 8, e59574.
5. Crabtree JE, Shallcross TM, Heatley RV, et al (1991). Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut, 32, 1473-7.
6. Gong YH, Sun LP, Jin SG, et al (2010). Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7, 241 subjects from China. Eur J Clin Microbiol Infect Dis, 29, 907-11.
7. He J, Qiu LX, Wang MY, et al (2012). Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet, 131, 1235-44.
8. Jarnicki A, Putoczki T, Ernst M (2010). Stat3: linking inflammation to epithelial cancer-more than a "gut" feeling? Cell Div, 5, 14.
9. Liao WC, Lin JT, Wu CY, et al (2008). Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma. Clin Cancer Res, 14, 428-34.
10. Ponder BA (2001). Cancer genetics. Nature, 411, 336-41.
11. Sipponen P (2002). Gastric cancer: pathogenesis, risks, and prevention. J Gastroenterol, 37, 39-44.
12. Sipponen P, Marshall BJ (2000). Gastritis and gastric cancer. Western countries. Gastroenterol Clin North Am, 29, 579-92, v-vi.
13. Smith AJ, D'Aiuto F, Palmen J, et al (2008). Association of serum interleukin-6 concentration with a functional IL6-6331T>C polymorphism. Clin Chem, 54, 841-50.
14. Sugimoto M, Yamaoka Y, Furuta T (2010). Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. World J Gastroenterol, 16, 1188-200.
15. Waldner MJ, Foersch S, Neurath MF (2012). Interleukin-6-a key regulator of colorectal cancer development. Int J Biol Sci, 8, 1248-53.
16. Wang J, He W, Liu J, et al (2012). Association of IL-6 polymorphisms with gastric cancer risk: evidences from a meta-analysis. Cytokine, 59, 176-83.
17. Yang L, Li Y, Ling X, et al (2011). A common genetic variant (97906C>A) of DAB2IP/AIP1 is associated with an increased risk and early onset of lung cancer in Chinese males. PLoS One, 6, e26944.
18. Yin YW, Sun QQ, Hu AM, et al (2012). Associations between interleukin-6 gene-174 C/G and-572 C/G polymorphisms and the risk of gastric cancer: a meta-analysis. J Surg Oncol, 106, 987-93.
19. Yu H, Pardoll D, Jove R (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer, 9, 798-809.
20. Yu J, Jia Y, Cheung KF, et al (2011). Polymorphisms in interleukin-6-6331 influences the susceptibility of a Chinese population to gastric cancer. Cancer Invest, 29, 564-72.
21. Yuzhalin A (2011). The role of interleukin DNA polymorphisms in gastric cancer. Hum Immunol, 72, 1128-36.